Sp1116

INFLAMMATORY BOWEL DISEASES

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

Experts in different fields across Latin American review and highlight selected abstracts presented at Digestive Disease Week® (DDW) 2023 in Spanish.

Presenter

Speaker Image for Oriana Damas
University of Miami Miller School of Medicine

Tracks

Related Products

Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for A HISPANIC DIET HIGH IN VEGETABLES IS ASSOCIATED WITH LOWER CLINICAL AND BIOCHEMICAL DISEASE ACTIVITY IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE: A LONGITUDINAL STUDY OF DISEASE ACTIVITY AND MICROBIOME SIGNATURES
A HISPANIC DIET HIGH IN VEGETABLES IS ASSOCIATED WITH LOWER CLINICAL AND BIOCHEMICAL DISEASE ACTIVITY IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE: A LONGITUDINAL STUDY OF DISEASE ACTIVITY AND MICROBIOME SIGNATURES
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…